Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
No Image Available

Ivabradine Hydrochloride API Suppliers & Bulk Manufacturers

Available Forms: API (drug substance)

Available Strengths: Supplied to an in-house or pharmacopoeial specification

Reference Brands: Corlanor, Procoralan

Category: Active Pharmaceutical Ingredient

Ivabradine hydrochloride is an If-channel blocker that slows the heart rate, used in heart failure and stable angina. Formulators, CDMOs and R&D teams source the API.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Ivabradine Hydrochloride API? List it or send an offer →

Product Description:

Ivabradine selectively blocks the If ('funny') current in the heart's sinus node, which slows the heart rate without lowering blood pressure or the force of contraction. It is approved for stable symptomatic chronic heart failure with reduced ejection fraction in adults and for paediatric heart failure due to dilated cardiomyopathy, as defined in the US label; in the EU it is also approved for symptomatic chronic stable angina (reference brand: Corlanor, Procoralan).

Specification at a glance

Traded formHydrochloride of the (S)-enantiomer; base CAS 155974-00-8; marked polymorphism.
CAS number148849-67-6
Molecular formulaC27H36N2O5 · HCl
Molecular weight505.05 g/mol (hydrochloride); 468.59 g/mol base
PharmacopoeiaNo Ph. Eur. monograph at the time of EU generic assessments (EMA, Ivabradine Accord); current Ph. Eur., USP and other pharmacopoeia status unverified. Supplied to an in-house specification.

Regulatory files and timing

The FDA list of Drug Master Files (third quarter 2026) shows 10 active Type II API DMFs for this molecule. Few filings usually means few qualified sources, so early contact with suppliers pays off. For Europe, ask whether the supplier holds a CEP or an EU ASMF and, for imports into the EU, a written confirmation.

Generic or biosimilar entry. United States: Generics/biosimilars on the market (Aug 2024). European Union: No confirmed date.

Handling and quality points

Ivabradine hydrochloride shows marked polymorphism, with seven crystalline forms reported in one EU assessment, and several forms are patent-protected, so the form must be fixed in the specification and confirmed by XRPD. It is a single (S)-enantiomer, with the (R)-isomer controlled as an impurity. Regulators expect an ICH M7 assessment of potentially mutagenic impurities and a nitrosamine risk assessment, as the molecule contains a tertiary amine.

Send an API enquiry All specialty APIs

Brand names are trademarks of their respective owners and identify the reference medicine only. Information is general and was checked in October 2026; confirm specifications and filings with the supplier before purchase.

Ivabradine Hydrochloride API — third party manufacturing & bulk supply

Ivabradine Hydrochloride API is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Ivabradine Hydrochloride API is supplied as API (drug substance) — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ivabradine Hydrochloride API listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Ivabradine Hydrochloride API →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Ask for a GMP certificate, specification and CoA, and an EU ASMF or US DMF letter of access for your filing. Polymorph data, chiral purity results, the mutagenic impurity and nitrosamine assessments and stability data are also routine.

Several forms have been patented, and EU generic dossiers have used different ones; one EMA assessment describes seven crystalline forms, with the delta-d form chosen for development. Pick a form your formulation and patent advisers accept, then make sure the supplier controls it in the API specification and shows it stays stable over shelf life.

Yes. PharmaTradz connects licensed manufacturers, CDMOs and R&D teams with GMP-compliant ivabradine hydrochloride makers after a first review of their documents. We keep your details private until both sides agree to talk.

Related Products

Baricitinib API

Strength:
USP grade or in-house specification

Form: API (drug substance)

Reference Brands: Olumiant

View Details
Ferric Derisomaltose API

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: API (drug substance)

Reference Brands: Monoferric, Monofer

View Details
Ferric Carboxymaltose API

Strength:
USP grade or in-house specification

Form: API (drug substance)

Reference Brands: Injectafer, Ferinject

View Details
Trabectedin API

Strength:
USP grade or in-house specification

Form: API (drug substance)

Reference Brands: Yondelis

View Details
Riociguat API

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: API (drug substance)

Reference Brands: Adempas

View Details
Acalabrutinib API

Strength:
USP grade or in-house specification

Form: API (drug substance)

Reference Brands: Calquence

View Details
Ferumoxytol API

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: API (drug substance)

Reference Brands: Feraheme, Rienso

View Details
Osimertinib Mesylate API

Strength:
Supplied to an in-house or pharmacopoeial specification

Form: API (drug substance)

Reference Brands: Tagrisso

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us